BPBT
REGN icon

Boston Private Bank & Trust’s Regeneron Pharmaceuticals REGN Stock Holding History

Boston Private Bank & Trust’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$106K Hold
235
– – ﹤0.01% 469
2014
Q4 		$96K Buy
235
+135
+135% +$53.1K ﹤0.01% 480
2014
Q3 		$36K Sell
100
-100
-50% -$33.5K ﹤0.01% 648
2014
Q2 		$56K Hold
200
– – ﹤0.01% 556
2014
Q1 		$60K Hold
200
– – ﹤0.01% 559
2013
Q4 		$55K Buy
200
+100
+100% +$28.8K ﹤0.01% 572
2013
Q3 		$31K Buy
+100
New +$26.3K ﹤0.01% 636

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Boston Private Bank & Trust's REGN Position: Q1 2015 in Review

Boston Private Bank & Trust held its Regeneron Pharmaceuticals (REGN) position steady in Q1 2015 at 235 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #469.

Boston Private Bank & Trust first reported a position in REGN in Q3 2013 and has held it in 7 quarters since. 509 funds tracked by Wall St. Rank hold REGN as of Q1 2015.

  • Boston Private Bank & Trust held 235 shares of Regeneron Pharmaceuticals worth $106K as of Q1 2015.
  • Boston Private Bank & Trust left its Regeneron Pharmaceuticals share count unchanged in Q1 2015.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Boston Private Bank & Trust's portfolio in Q1 2015, its #469 holding.
  • Boston Private Bank & Trust first reported a position in Regeneron Pharmaceuticals in Q3 2013 and has held it in 7 quarters since.
  • 509 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2015.

Based on Boston Private Bank & Trust's 13F filing for Q1 2015, filed 9 Apr 2015.